Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Andreone

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
The New Microbiologica|June 21, 2021
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs eraBarbara Rossetti, Elisabetta Loggi, Chiara Spertilli Raffaelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2014
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug AgencyFloriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, et al.
European Journal of Internal Medicine|July 4, 2020
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up studyStefano Gitto, Nicola De Maria, Luca Marzi, et al.
Gastrointestinal Tumors|November 27, 2019
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of ExperienceGiulia Rovesti, Giulia Orsi, Andrikou Kalliopi, et al.
Vaccine|February 6, 2008
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individualsPaola Rizza, Imerio Capone, Francesca Urbani, et al.
Internal and Emergency Medicine|November 20, 2023
Physical activity in liver transplant recipients: a large multicenter studyStefano Gitto, Lucia Golfieri, Filippo Gabrielli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisLars Bossen, Paola Rebora, Francesca Bernuzzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2018
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovirMauro Viganò, Alessandro Loglio, Sara Labanca, et al.
Minerva Gastroenterology|May 10, 2023
Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter studyStefano Gitto, Lucia Golfieri, Francesco Sofi, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trialGideon M Hirschfield, Christopher L Bowlus, David E J Jones, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
The New Microbiologica|June 21, 2021
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs eraBarbara Rossetti, Elisabetta Loggi, Chiara Spertilli Raffaelli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2014
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug AgencyFloriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, et al.
European Journal of Internal Medicine|July 4, 2020
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up studyStefano Gitto, Nicola De Maria, Luca Marzi, et al.
Gastrointestinal Tumors|November 27, 2019
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of ExperienceGiulia Rovesti, Giulia Orsi, Andrikou Kalliopi, et al.
Vaccine|February 6, 2008
Evaluation of the effects of human leukocyte IFN-alpha on the immune response to the HBV vaccine in healthy unvaccinated individualsPaola Rizza, Imerio Capone, Francesca Urbani, et al.
Internal and Emergency Medicine|November 20, 2023
Physical activity in liver transplant recipients: a large multicenter studyStefano Gitto, Lucia Golfieri, Filippo Gabrielli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisLars Bossen, Paola Rebora, Francesca Bernuzzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2018
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovirMauro Viganò, Alessandro Loglio, Sara Labanca, et al.
Minerva Gastroenterology|May 10, 2023
Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter studyStefano Gitto, Lucia Golfieri, Francesco Sofi, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trialGideon M Hirschfield, Christopher L Bowlus, David E J Jones, et al.
Pageof 19